¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÏÇÐȸ AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1 : 2018-11-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѾÏÇÐȸ AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1 : 2018-11-15
±³À°ÀÏÀÚ : 2018-11-15
±³À°Àå¼Ò : ¼­¿ï·Ôµ¥È£ÅÚ Crystal Ballroom èâ  
±³À°ÁÖÁ¦ : AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer4@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢±â°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 9 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í 1.Á¶±âµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 20¸¸¿ø, 2)ºñȸ¿ø: 30¸¸¿ø, 3)Çлý,Trainee: 10¸¸¿ø/ 2.»çÀüµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 30¸¸¿ø, 2)ºñȸ¿ø: 40¸¸¿ø, 3)Çлý,Trainee: 15¸¸¿ø/ 3.ÇöÀåµî·Ï: 1)ȸ¿ø(AACR ¶Ç´Â KCA): 40¸¸¿ø, 2)ºñȸ¿ø: 50¸¸¿ø, 3) Çлý,Trainee: 20¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 08:30~08:55 Precision medicine in lung cancer: Prime time  ¾È¸íÁÖ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 08:55~09:20 The Umbrella Trial in GC: Understanding the disease through genomics  ÀÌÁö¿¬(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 09:20~09:45 Tumor agnostic drug development: Revisiting the score card in 2018  Alexander E. Drilon(Memorial Sloan Kettering Cancer Center, USA) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 09:45~10:10 Overview of genomic technologies  Elaine R. Mardis(Nationwide Children) 
È޽Ġ11¿ù 15ÀÏ  10:10~10:30 È޽Ġ () 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 10:40~11:20 Precision medicine in lung cancer: Opportunities & challenges  Waun Ki Hong(The University of Texas MD Anderson Cancer Center, USA) 
½Ä»ç 11¿ù 15ÀÏ  11:20~12:00 ½Ä»ç  () 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 11:20~11:50 Emerging biomarker strategies for Immuno-Oncology  Aurora Seminara(BMS Medical, Immuno-Oncology-Biomarker & Diagnostics) 
±³À°½Ã°£ 11¿ù 15ÀÏ Sapphire Room 11:20~12:00 Optimized treatment strategy in mCRC with recent precision medicine  À̸í¾Æ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Emerald Room 11:20~12:00 Grounreaking efficacy of osimertinib as a new SoC for EGFRm NSCLC management  ±èÇý·Ã(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 12:00~12:15 K-MASTER Project  ±è¿­È«(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 12:15~12:30 Implementation of clinical sequencing in cancer treatment  To be announced() 
Åä·Ð 11¿ù 15ÀÏ Crystal Ballroom 12:30~13:00 Discussion and Q&A : Regulatory considerations for NGS Oncopanel development  Aurora Seminara, ±è¿­È« ¿Ü(BMS Medical, Immuno-Oncology-Biomarker & Diagnostics, °í·ÁÀÇ´ë ¿Ü) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:00~13:25 Knowledge to practice using cancer genomics  À̼¼ÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:25~13:50 Genomic and epigenomic profiles of Asian gastrointestinal malignancies  Patrick Tan(Duke-NUS Medical School, Singapore) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 13:50~14:15 Title to be announced  ±èÁ¾ÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 14:15~14:40 Implementing cancer genomics into the diagnosis and treatment of pediatric cancer  Elaine R. Mardis(Nationwide Children) 
È޽Ġ11¿ù 15ÀÏ  14:40~15:00 È޽Ġ () 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:00~15:25 Current status of the Korean Cancer Precision Mecidine Project, K-MASTER  ±è¿­È«(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:25~15:50 Impact of clinical NGS: Lessons lung cancer  Jessica Jiyeong Lin(Massachusetts General Hospital Cancer Center, USA) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 15:50~16:15 Updated results and new studies in the nation-wide NGS-based new agent development  Atsushi Ohtsu(National Cancer Center Hospital East, Japan) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 16:15~16:40 The future of cancer care through biologic profiling and big data  Thomas D. Brown(Swedish Cancer Institute, USA) 
±³À°½Ã°£ 11¿ù 15ÀÏ Crystal Ballroom 16:40~17:10 Spotlight on Proferred Papers Session 1  To be announced() 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÏÇÐȸ AACR-KCA Joint Conference on Precision Medicine in Solid Tumors 1 : 2018-11-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÇѸ²´ëÇб³¼º½Éº´¿ø °¡Á¤ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2018-11-15
´ÙÀ½±Û ÇѸ²´ëÇб³¼º½Éº´¿ø ÇÑÀÌȸ (how to avoid missing central vertigo) : 2018-11-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21000 ºÎ»ê ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦19Â÷ Çмú´ëȸ : 2024-06-23 0 8 2024-06-17
20999 ¼­¿ï 2024³â 6¿ù ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 9 2024-06-17
20998 ¼­¿ï Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 4 2024-06-17
20997 ¼­¿ï ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23 0 7 2024-06-17
20996 ´ë±¸ 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 5 2024-06-17
20995 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 22 2024-06-16
20994 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 11 2024-06-16
20993 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø Á¦6ȸ ÀÎÇÏÇǺνÉÆ÷Áö¾ö : 2024-06-22 0 7 2024-06-16
20992 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 9 2024-06-16
20991 ¼­¿ï 2024³â Á¦2Â÷ ´ëÇѳëÀÎÀÇÇÐ ¼¼ºÎÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 13 2024-06-16
20990 ¼­¿ï ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2024-06-22 0 7 2024-06-16
20989 °æ±â 2024³â ¾È¾ç½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 3 2024-06-16
20988 ¼­¿ï ´ëÇѼҾƳ»ºÐºñÇÐȸ Á¦18Â÷ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 4 2024-06-16
20987 ¼­¿ï 2024³â Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 4 2024-06-16
20986 ¼­¿ï 2024 ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ ³ú½Å°æÁ¶Àý Moving Symposium : 2024-06-22 0 5 2024-06-16
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷